OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Suvoda announced that as part of its single platform rollout, its eCOA solution is moving to the second phase of the Early Adopter program. This solution, designed to work with Suvoda IRT and eConsent, focuses on addressing eCOA challeneges such as gaps in overall delivery and execution quality, time consuming translations and localization processes, and logistics related to device management.
Read more about the solution here.